Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31true2024-01-01No description of principal activityThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.1truefalse1false 13121089 2024-01-01 2024-12-31 13121089 2023-01-01 2023-12-31 13121089 2024-12-31 13121089 2023-12-31 13121089 c:Director1 2024-01-01 2024-12-31 13121089 d:CurrentFinancialInstruments 2024-12-31 13121089 d:CurrentFinancialInstruments 2023-12-31 13121089 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 13121089 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 13121089 d:ShareCapital 2024-12-31 13121089 d:ShareCapital 2023-12-31 13121089 d:RetainedEarningsAccumulatedLosses 2024-12-31 13121089 d:RetainedEarningsAccumulatedLosses 2023-12-31 13121089 c:OrdinaryShareClass1 2024-01-01 2024-12-31 13121089 c:OrdinaryShareClass1 2024-12-31 13121089 c:OrdinaryShareClass1 2023-12-31 13121089 c:OrdinaryShareClass2 2024-01-01 2024-12-31 13121089 c:OrdinaryShareClass2 2024-12-31 13121089 c:OrdinaryShareClass2 2023-12-31 13121089 c:FRS102 2024-01-01 2024-12-31 13121089 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 13121089 c:FullAccounts 2024-01-01 2024-12-31 13121089 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13121089 6 2024-01-01 2024-12-31 13121089 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 13121089









SERENE SEDATION LTD

UNAUDITED

FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
SERENE SEDATION LTD
REGISTERED NUMBER: 13121089

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 4 
75,000
75,000

  

Creditors: amounts falling due within one year
 5 
(76,553)
(75,590)

Net current liabilities
  
 
 
(76,553)
 
 
(75,590)

Total assets less current liabilities
  
(1,553)
(590)

  

Net liabilities
  
(1,553)
(590)


Capital and reserves
  

Called up share capital 
 6 
100
100

Profit and loss account
  
(1,653)
(690)

  
(1,553)
(590)


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 September 2025.



................................................
M I H Kassam
Director

The notes on pages 2 to 3 form part of these financial statements.

Page 1

 
SERENE SEDATION LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Serene Sedation Ltd is a private company, limited by shares, incorporated in England and Wales with the registration number 13121089. The address of the registered office is Anglia House 6 Central Avenue, St Andrews Business Park, Thorpe St Andrew, Norwich, Norfolk, NR7 0HR.
The financial statements are presented in sterling, which is the functional currency of the company, and rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The director has, at the time of approving the financial statements, a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they adopt a going concern basis of accounting in preparing the financial statements. The director has considered a period of 12 months from the balance sheet date.

 
2.3

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.4

Creditors

Short-term creditors are measured at the transaction price.

 
2.5

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees



The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

Page 2

 
SERENE SEDATION LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Fixed asset investments





Unlisted investments

£



Cost or valuation


At 1 January 2024
75,000



At 31 December 2024
75,000





5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other creditors
76,053
75,590

Accruals and deferred income
500
-

76,553
75,590



6.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



51 (2023 - 51) Ordinary A shares of £1.00 each
51
51
49 (2023 - 49) Ordinary B shares of £1.00 each
49
49

100

100





7.


Related party transactions

At 1 January 2023 the Company owed the director £75,590, during the year expenses  were paid of £463, leaving a balance of £76,053 due to them as at 31 December 2024.

Page 3